chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reported to the pharmacy approximately 10 minutes after receiving the vaccination.  He felt dizzy and said his throat felt tight.  He said it felt as though there was something in his throat that he needed to clear.  His lips felt slightly numb when he initially arrived here, but the numbness went away after he sat for a few minutes.  His breathing remained normal-there was no swelling of the lips/tongue.  His throat continued to feel more obstructed after another 15 minutes.  He could still breathe/speak normally.  At this time I called 911 and shortly after administered an EpiPen injection.  The patient felt better almost immediately.
Initial report received on 07 December 2009 from a consumer, who is the patient. A 35 year old female patient, with no known allergies and a history of hypothyroidism treated with LEVOXYL, received a dose of H1N1 (lot number unknown) on 04 November 2009. As per the patient, she thought that she received more than a 0.5 ml dose. The patient was 32 weeks pregnant at the time of vaccination. The date of her last menstrual period was not reported and the estimated date of confinement was 03 January 2010 (reported as 2009). The patient's obstetric history was not reported. On 06 November 2009, the patient developed congestion, a sore throat, a sinus infection, and laryngitis. Corrective treatment was not reported. At the time of the report, the symptoms persisted and the patient had not recovered.
pt devel urticaria & swelling @ the inj site the day p/inj was given;
Received the vaccine in the right arm and it felt like it went to sleep from the elbow down; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at site of right arm on 02Feb2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced received the vaccine in the right arm and it felt like it went to sleep from the elbow down. it's been about 2 hours and is persisting. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Patient scheduled for second Moderna vaccine on 2-19-2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021). On 19-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified blood thinner.  No Treatment medication was reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 09-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021). On 19-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient scheduled for second Moderna vaccine on 2-19-2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified blood thinner.  No Treatment medication was reported.
Approximately 30 minutes after receiving the vaccination dad had a seizure, and he continued having seizures for 24 hours.  He developed a low grade fever of 99.4 for 24 hours.  He was very ill for 8 days and has been continuing to recover slowly.
pt recvd vax; severe nasal congestion & green d/c on 6apr95; loose cough, T of 102;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 15-SEP-2009, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 04-JAN-2014, the patient was treated for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.  The outcome of the events was unknown. Causality assessment was related.
5x5 erythematous area on lt deltoid w/o pain in site; lasted 22MAR95 to 24MAR95 to date; instructed to use ice to site APAP for pain PRN;
After receiving the vaccine, my chest/heart felt tight and heart hurt some but I thought could be because of masked during the waiting period. Heart symptoms of tight(feels like squeeze), fluttering (pulse moving up and down) have not subsided as of yet (now at 24hrs after receiving the dose).  Last night I had a few brief chest pains but none today.
shingles; soreness near her right ear; soreness right side of her head,  neck and under her jaw; head soreness; jaw soreness; rash; tiredness; chills; muscle ache; pain in arm; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PREVNAR) for prophylaxis.   The patient's past medical history included chickenpox (had chicken pox when she was young). Previously administered products included Shingrix with an associated reaction of chills (for tolerance to the 1st dose refer case US2020052377).   On 17th March 2020, the patient received the 2nd dose of Shingrix. On 13th March 2020, the patient received PREVNAR. In March 2020, less than a week after receiving Shingrix, the patient experienced tiredness, chills, muscle pain and pain in arm. On 19th March 2020, the patient experienced shingles, ear pain, neck pain, headache, jaw pain and rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the shingles, ear pain, neck pain, headache, jaw pain and rash were unknown and the outcome of the tiredness, chills, muscle pain and pain in arm were recovered/resolved.   It was unknown if the reporter considered the shingles, tiredness, chills, muscle pain, pain in arm, ear pain, neck pain, headache, jaw pain and rash to be related to Shingrix.  Additional details were provided as follows: The patient received Prevnar vaccine in her left arm. The patient received Shingrix vaccine on right arm and stated she did have some muscle aches, chills and tiredness with a sore right arm for about three days. 2 days after receiving vaccination, the patient started to have some soreness near her right ear and right side of her head,  neck and under her jaw. She stated it looked like a rash and day of reporting she was seen by her doctor and was diagnosed with shingles. Consent to follow up was granted.
Hair began falling out in small amounts at first but after 3rd vaccination, a large amount comes out daily
Patient was given a dose of Pfizer pediatric covid vaccine that had been refrigerated for 76 days.  Manufacturer recommended refrigerated storage is 70 days.  Parent notified of vaccine error and given CDC recommendations.  Parent chose not to re-vaccinate at this time.  No side effects or adverse reactions noted from the vaccine per mother.
W/in 24 to 48 hrs developed h/a, fever & rash; Tx DPH & advised by her MD not to receive additional doses;
Was administered FLUBOK. Started local reaction to injection site with redness and swelling elevated pulse and shortness of breath. Nurse administered EPI and employee was transferred to Emergency room.
left hand was tingly/pins and needles/feeling lots of pins and needles in my left hand/tingling/ pins and needles in both hands and both legs/left foot and calf tingling; Hand numbness and tingling was very intense; hand numbness and tingling was very intense to the point that it hurt; Hand was tingly/pins and needles and kept me awake; Left arm weakness/ some weakness in my legs; Some loss of balance when walking occasionally; My left hand felt very cold; My left neck lymph node got tender and swollen; My left neck lymphnode got tender and swollen/ felt my lymph nodes in my neck and jaw somewhat swollen; Headache; Felt congested; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date not reported), via an unspecified route of administration, administered in the left arm on 22Apr2021, as second dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 23Apr2021, the patient experienced my left neck lymph node got tender and swollen, my left neck lymph node got tender and swollen/felt my lymph nodes in my neck and jaw somewhat swollen. On an unspecified date in Apr2021, the patient experienced headache and felt congested. On an unspecified date in May2021, the patient experienced left hand was tingly/pins and needles/feeling lots of pins and needles in my left hand/tingling/ pins and needles in both hands and both legs/left foot and calf tingling, hand numbness and tingling was very intense, hand numbness and tingling was very intense to the point that it hurt, hand was tingly/pins and needles and kept me awake, left arm weakness/ some weakness in my legs, some loss of balance when walking occasionally, and my left hand felt very cold. Patient had 2nd Pfizer dose on 22Apr2021 in the left arm. Next day, patient's left neck lymph node got tender and swollen for few days. Few days later, patient had a headache and felt congested. During the first week, one night, patient's left hand was tingly/pins and needles and kept him/her awake. Then on 09May2021, he/she woke up with a headache and felt lymph nodes in neck and jaw somewhat swollen. He/She started feeling lots of pins and needles in left hand and some weakness in legs. Also felt some loss of balance when walking occasionally. Patient also noted his/her left hand felt very cold. Last night he/she woke up around 4AM with tingling/ pins and needles in both hands and both legs. They lasted until patient got up. Now, patient have tingling in left hand, left arm weakness and left foot and calf tingling. Patient was concerned about how these side effects are lasting. Patient stated he/she will make an appointment with a neurologist. Patient stated any insight would help. The outcome of all events was unknown.  Information on the lot/batch number has been requested.
@ f/u visit 4 days p/vax was given pt was febrile 101.7 R (temp ranged from 100-102); pt was very irritable w/dec appetite & activity level;
felt like bee sting on injection site; red patch at injection site; uncomfortable at injection site; irritating but not itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (uncomfortable at injection site), VACCINATION SITE IRRITATION (irritating but not itchy), VACCINATION SITE PAIN (felt like bee sting on injection site) and VACCINATION SITE ERYTHEMA (red patch at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE DISCOMFORT (uncomfortable at injection site), VACCINATION SITE IRRITATION (irritating but not itchy) and VACCINATION SITE ERYTHEMA (red patch at injection site). On 16-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (felt like bee sting on injection site). On 17-Feb-2021, VACCINATION SITE PAIN (felt like bee sting on injection site) had resolved. At the time of the report, VACCINATION SITE DISCOMFORT (uncomfortable at injection site), VACCINATION SITE IRRITATION (irritating but not itchy) and VACCINATION SITE ERYTHEMA (red patch at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-Jul-2021 and contains no new information.
pt recvd vax & 2hrs p/vax exp fever,pallor,h/;sx were treated w/PCN;sx persist;MD feels that sx are unrelated to vax;a family member has strep & scarlet fever & it is felt that pt probably had strep
Flashy vision, slurred speech, delayed verbalization after thought. Gradually improved. Headache started, right arm and hand got swollen and tingly. Right side of mouth and face got tingly as well as partial right side of inside of throat.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 2, single (Lot number: Er8727), in left arm and on 02Nov2021 as dose 3 (booster), single (Lot number: Fe3592) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "sickle cell trait" (unspecified if ongoing); "Severe allergies" (unspecified if ongoing); "Known allergies: I'm allergic to shellfish" (unspecified if ongoing); "Known allergies: cedar" (unspecified if ongoing); "Known allergies: pollen" (unspecified if ongoing); "Known allergies: dustmites" (unspecified if ongoing); "Known allergies: dander" (unspecified if ongoing). Concomitant medication(s) included: PATADAY taken for hypersensitivity; PRAVASTATIN taken for hypersensitivity; FLONASE [FLUTICASONE PROPIONATE]. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19. . Paxlovid taken as COVID 19 treatment from 05May2022 to 10May2022.  No follow-up attempts are possible. No further information is expected.
Pneumo Conjugate (Prevnar 20) given in error. (Should have received Prevnar13). No known events.
Child received 2 immunization injection Thurs., May 1st. Mother noticed a rash Saturday afternoon. The rash was raised above the skin and at first "looked like mosquito bites" per mother. Rash later that evening turned into welts "like hives". Oatmeal baths x2, BENADRYL po x2, steroid cream application. Sunday c/o some itching. No pain or fever. No problems breathing. Rash resolved by 5-5-14.
I have not had an infection in either foot since I started taking these vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 08Apr2021 15:00 (Lot number: er8729) at the age of 57 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "I have suffered from infections in between my small toes on both feet" (not ongoing), notes: infections in between toes on both feet for 15-20 years because of Athletes foot.; "Athletes foot" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "known allergies: Codeine". Vaccination history included: Bnt162b2 (Dose 1, administration time=15:00, anatomical location=Right arm, lot number=pn6199), administration date: 19Mar2021, when the patient was 57 years old, for COVID-19 immunization. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 08Apr2021, outcome "unknown", described as "I have not had an infection in either foot since I started taking these vaccines". Therapeutic measures were not taken as a result of therapeutic response unexpected.  Additional information: No other vaccines in four weeks, no Covid prior to vaccination. The patient has not tested Covid post vaccination.  No follow-up attempts are possible. No further information is expected.
One minute after receiving the vaccine my face and tongue began to tingle. Then they began to swell. The swelling lasted for 4 hours. 16 hours after the vaccine I had a fever of 101 degrees Fahrenheit, chills, muscle aches, a headache, and I was vomiting. This lasted for 36 hours.
Hospitalized with myocarditis post Pfizer vaccine on 12/14/2021   he had completed his Moderna 2 dose series and was boosted with Pfizer vaccine.  Patient unresponsive at home requiring shock from defibrillator on 12/18 out of hospital cardiac arrest, pt does have history of congenital heart disease.
Severe Flu-like symptoms, Joint pain, Skin sensitivity, Difficulity urinating, Fever, Chills, fatigue
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Jan2021 as dose 1, single (Lot number: EL8982), in left arm, on 15Feb2021 as dose 2, single (Lot number: EL9265), in left arm and on 04Oct2021 as dose 3 (booster), single (Lot number: 30155BA) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "ALCL Alk+ (history)" (unspecified if ongoing), notes: Other medical history: ALCL Alk+ (history); "TMD" (unspecified if ongoing), notes: Other medical history: TMD; "arthritis" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codiene, reaction(s): "Known allergies Codiene", notes: Known allergies: Codiene. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: two negative tests; Negative, notes: two negative tests; Positive, notes: Tested positive with mild symptoms. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Follow-up attempts are completed. No further information is expected.
Flu like symptoms (fever, body aches, lethargy) that lasted the entire day.
Fatigue beginning about 6 hours after the injection, fever and nausea beginning 12 hours after the injection and lasting 24 hours.
Face flushing, stomach upset, headache. Immediate (within 1 minute) of receiving vaccine.
Patient stated that approximately 6 hours after receiving vaccination she became dizzy, developed a high fever, and was sweating. She then proceeded to pass out.
swollen lymph node; This case was reported by a pharmacist via call center representative and described the occurrence of axillary lymph nodes enlarged in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number MX2LT, expiry date 25th May 2021) for prophylaxis.   On 23rd February 2019, the patient received the 1st dose of Shingrix .5 ml. On 24th February 2019, 1 days after receiving Shingrix, the patient experienced axillary lymph nodes enlarged. On an unknown date, the outcome of the axillary lymph nodes enlarged was not recovered/not resolved.   It was unknown if the reporter considered the axillary lymph nodes enlarged to be related to Shingrix.  Additional details were reported as follows: The patient received his 1st dose of Shingrix, the next day he experienced a swollen lymph node under the arm where he received the shot.  It was unknown how long it took to resolve. The reporter had consented to follow up.
PATIENT COMPLAINED OF REDNESS, RASH, SWELLING AND ITCHING SOON AFTER GETTING THE VACCINE. IT GOT WORSE THE NEXT DAY.
This second dose was administered two weeks earlier than the indicated 28 day period by error. No signs or symptoms.
Had "flu-like" symptoms with low grade fever, chills, and muscle spasms in her chest area last from 4 p.m. on 7/31/19 until 6 a.m. on 8/1/19.  Stated she "felt like she had a sunburn and that her skin hurt when she had goosebumps with the chills".   Took two tablets of Tylenol PM at bedtime and then again during the night.  Also, left deltoid hurt for several days post vaccination but no swelling or redness.
Information has been received from a pharmacist concerning 3 patients who "within the last two weeks" (on approximately 01-NOV-2010) were vaccinated with doses of PNEUMOVAX 23 (with two different lot numbers, one of them was lot number 667271/0880Z). The pharmacist reported that within the last two weeks (on approximately 01-NOV-2010) the patients complained of soreness, redness, swelling, and a "burning pain" in their upper arms. At the time of the report the outcome of the patients was unknown. It was unspecified if the patients sought medical attention. Follow up information was received via telephone call from a doctor of pharmacy concerning a 65 year old female patient, who on 10-NOV-2010 was vaccinated with a dose of PNEUMOVAX 23 (Lot # 667271/0880Z EXP 11-DEC-2011). The pharmacist reported that the patient experienced soreness, redness, swelling, and a "burning pain" in her upper arms. She had no fever but was issued a prescription for BACTRIM in case she got worse. At the time of the report, the outcome of the patient was unknown. This is one of three reports from the same source. Additional information is not expected.
right deltoid swelling, erythema 6cm x 7cm mild pruritus, local treatment ibuprophen, Benadryl, Ice, notify if symptoms increase.
The pt experienced a sudden loss of vision, (over night - blurred). The pt experienced a problem with balance and memory. Vision was lost for 3 days following 2nd shot. Diagnosis of multiple sclerosis verified in medical records. follow up report received 11/20/02 states "vision & balance, sudden loss of vision occurred about 4 days after second shot". Per review of medical records: MS (multiple sclerosis) was diagnosed sometime between 10/11/1999 when MRI ordered, and 04/2000.
Slight metallic taste on front of tongue starting 2-4 minutes after injection, lasting at least 30 minutes. (Still experiencing it as I write this.)